Yahoo Web Search

Search results

    • Moderna reports $1.2bn net loss in Q1 2024

      Moderna reports $1.2bn net loss in Q1 2024

      Pharmaceutical Technology via Yahoo Finance· 4 days ago

      Net product sales plummeted by 91% compared to Q1 2023. This downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines....

    • Moderna (NASDAQ:MRNA) PT Raised to $106.00

      ETF DAILY NEWS· 11 hours ago

      Moderna (NASDAQ:MRNA – Free Report) had its price target increased by Canaccord Genuity Group from $91.00 to $106.00 in a report published on Friday, Benzinga reports. Canaccord ...